SCHEMBL23882575

SCHEMBL23882575

COc1ccc2nc(COC(C)=O)[nH]c(=O)c2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.58
HSD17B10 Q99714 2/20 0.58
LMNA P02545 1/20 0.58
TUBB4A P04350 3/20 0.50
TUBB P07437 3/20 0.50
TUBA3C P0DPH7 3/20 0.50
TUBA1B P68363 3/20 0.50
TUBA4A P68366 3/20 0.50
TUBB4B P68371 3/20 0.50
TUBB3 Q13509 3/20 0.50
TUBB2A Q13885 3/20 0.50
TUBB8 Q3ZCM7 3/20 0.50
TUBA3E Q6PEY2 3/20 0.50
TUBA1A Q71U36 3/20 0.50
TUBA1C Q9BQE3 3/20 0.50
TUBB6 Q9BUF5 3/20 0.50
TUBB2B Q9BVA1 3/20 0.50
TUBB1 Q9H4B7 3/20 0.50
ROCK2 O75116 2/20 0.50
ALDH1A1 P00352 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9556162 0.85 KDM4E (0.51) KDM4EHSD17B10LMNATUBB4ATUBB
SCHEMBL9555823 0.82 ALDH1A1 (0.44) KDM4EHSD17B10LMNATUBB4ATUBB
SCHEMBL21127512 0.81 KDM4E (0.56) KDM4EHSD17B10LMNATUBB4ATUBB
SCHEMBL7411788 0.81 KDM4E (0.67) KDM4EHSD17B10LMNATUBB4ATUBB
SCHEMBL23882552 0.81 RAB9A (0.69) KDM4EHSD17B10LMNATUBB4ATUBB
SCHEMBL6929859 0.80 KDM4E (0.65) KDM4EHSD17B10LMNATUBB4ATUBB
SCHEMBL2180069 0.80 RAB9A (0.63) KDM4ELMNAALDH1A1MAPK1POLB
SCHEMBL23882607 0.80 KDM4E (0.65) KDM4EHSD17B10LMNATUBB4ATUBB
SCHEMBL30186039 0.80 KDM4E (0.65) KDM4EHSD17B10LMNATUBB4ATUBB
SCHEMBL9386679 0.79 ALDH1A1 (0.44) KDM4EHSD17B10LMNAALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198191-A1 QUINAZOLINONE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER ENYO PHARMA (FR) 2021-10-07 WO disclosed
WO-2021198191-A1 QUINAZOLINONE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER ENYO PHARMA (FR) 2021-10-07 WO disclosed